- Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon
- Author: Mr Mfazo Hove
- Published: May 22, 2025
- Last Updated: July 21, 2026
In short. Blue Fin Vision® provides consultant ophthalmic-led xanthelasma removal in Chelmsford at Phoenix Hospital, giving patients across Essex the same consultant-led pathway as our London clinics, closer to home.
Essex Convenience, Consultant-Led Care
Xanthelasma sits on the eyelid, so it is worth choosing consultant ophthalmic-led care that protects the lid margin and a natural contour rather than a general aesthetic service. Our Chelmsford clinic at Phoenix Hospital brings private xanthelasma removal in Chelmsford to Essex, with the same consultant-led pathway as our London sites, so you do not need to travel into the capital.
Patients visit our Chelmsford clinic from across Essex, including Chelmsford, Brentwood, Braintree, Witham, Maldon, Colchester and the surrounding towns.
What Xanthelasma Is, in Brief
Xanthelasma in Chelmsford is a benign, cholesterol-rich plaque on the eyelids that does not usually affect sight¹. It does not mean you definitely have raised cholesterol, but because it can be associated with lipid abnormalities and cardiovascular risk² ³, a GP lipid check is sensible.
Treatment is by consultant-led surgical excision. At Blue Fin Vision®, xanthelasma treatment in Chelmsford is by surgical excision, carried out under local anaesthetic as a day case, with the plaque carefully excised and the skin closed to protect the eyelid contour⁴. Xanthelasma surgery by excision is recognised in the literature as a mainstay of treatment⁵. Your consultant confirms whether excision is appropriate for your lesions at assessment.
For a fuller explanation of the condition and how it is treated, see our guide to what is xanthelasma?.
Why Blue Fin Vision® in Essex
Our Chelmsford service is delivered at Phoenix Hospital Chelmsford, Essex Healthcare Park, West Hanningfield Road, Chelmsford, CM2 8HN, by the same consultant-led team as our London clinics, under Mr Mfazo Hove, in CQC-registered facilities with a Doctify rating of 4.96 out of 5 from 557+ verified reviews.
Xanthelasma removal in Chelmsford is carried out in a main operating theatre. This hospital setting adds to the cost compared with our clinic-based option at The Harley Street Eye Centre but saves patients across Essex a journey into London. Your consultant will help you choose the most appropriate and cost-effective setting.
Frequently Asked Questions
Where in Essex is treatment carried out?
At Phoenix Hospital Chelmsford, Essex Healthcare Park, West Hanningfield Road, CM2 8HN.
Is xanthelasma dangerous?
The plaques are benign, but they can be a marker of cardiovascular risk, so a lipid check is worthwhile².
Is the procedure painful?
Xanthelasma removal is usually performed under local anaesthetic as a day case, so discomfort is minimal; mild soreness afterwards is normal.
How long is recovery?
Most people resume light activities within a few days, with redness or swelling settling within about a week.
Does xanthelasma removal improve vision?
Usually no. It is done for appearance and eyelid contour.
Book a consultant-led xanthelasma assessment at our Chelmsford clinic and receive a tailored plan, an exact price, and advice on whether lipid testing is appropriate.
Related Pages
References
- Nair PA, Singhal R. Xanthelasma palpebrarum: a brief review. Clin Cosmet Investig Dermatol. 2018;11:1-5.
- Christoffersen M, Frikke-Schmidt R, Schnohr P, Jensen GB, Nordestgaard BG, Tybjaerg-Hansen A. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ. 2011;343:d5497.
- Dey A, Aggarwal R, Dwivedi S. Cardiovascular profile of xanthelasma palpebrarum. Biomed Res Int. 2013;2013:932863.
- Lee HY, Jin US, Minn KW, Park YO. Outcomes of surgical management of xanthelasma palpebrarum. Arch Plast Surg. 2013;40(4):380-386.
- Yee DA, Zhou AE, Khachemoune A. Examining treatment strategies for xanthelasma palpebrarum: a comprehensive literature review of contemporary modalities. Arch Dermatol Res. 2024;316(5):149.
